BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Alcohol
,
Rapamycin
,
rs2300478
,
ZBTB7A
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
methionine aminopeptidases
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for methionine aminopeptidases
Explore Curated Studies Results
Literature
Most Relevant Literature
Biochemical characterization of recombinant methionine aminopeptidases (MAPs) from Mycobacterium tub…
Methionine aminopeptidase 2 and cancer.
A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patien…
Hydroxamic acids as potent inhibitors of Fe(II) and Mn(II) E. coli methionine aminopeptidase: biolog…
Expression and characterization of Mycobacterium tuberculosis methionine aminopeptidase type 1a.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evexomostat Plus Alpelisib and Fulvestrant in Postmenopausal Women at Risk for Hyperglycemia With Br…
Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 …
Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female …
ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity
An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syn…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ